Clinical and pharmacological observations of the effects of 9‐α‐bromo‐11‐β‐ketoprogesterone in patients with carcinoma of the breast
暂无分享,去创建一个
R. Jones | H. Lessner | U. Jonsson | O. S. Roath | J. Colsky | R. G. Alper | O. Roath
[1] Davis Me,et al. 9 alpha-Bromo-11-ketoprogesterone; another new orally effective substance with progestational activity. , 1957 .
[2] A. Lipschutz,et al. Antifibromatogenic Potency of 9α-fluoro Derivatives of Progesterone , 1956, Nature.
[3] R. Hertz,et al. Progestational Activity of Halogenated Corticosteroids and Related Compounds in Rabbit and Monkey.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[4] E. Jensen,et al. THE DEPRESSION OF GROWTH OF THE UTERUS, ADRENALS, AND OVARIES BY FLUORINATED STEROIDS IN THE PREGNANE SERIES , 1955, The Journal of experimental medicine.
[5] W. Ganong,et al. PHARMACOLOGICAL STUDIES IN MAN OF 11‐, 17‐, AND 21‐HYDROXY DERIVATIVES OF PROGESTERONE AND THEIR FLUORINATED ANALOGS , 1955, Annals of the New York Academy of Sciences.
[6] P. Numerof,et al. 9α-Halo-11β-Hydroxy and 11-Keto Derivatives of Progesterone, Desoxycorticosterone and 17α-Hydroxyprogesterone , 1955 .